EphiWel
Natural health product licensed in Canada
- Other names
- Ephedrine-Well, LiboWell-Well-Ephedrine
- Licence holder
- 110 Formulas Corp.
- NPN or DIN-HM
- 80096865
- Status
- Inactive licence
- Licence date
- 29 January 2020
- Revision date
- 29 August 2022
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| l-éphédrine Source : Chlorhydrate de l-éphédrine | 8 mg | Not calculated |
Non-medicinal ingredients
Phosphate dicalcique, Stéarate de magnésium, Cellulose, Croscarmellose de sodium, Dioxyde de silicium colloïdal
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Used as a decongestant/to relieve nasal congestion (due to hay fever/allergic rhinitis/allergies/sinusitis/the common cold/flu).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking medication and/or natural health products for allergy symptoms, asthma, cough/cold or weight control . Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking other products containing caffeine, ephedrine, phenylpropanolamine or pseudoephedrine. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have cardiovascular disease, diabetes, difficulty in urination due to prostate enlargement, glaucoma, thyroid problems, seizure disorders or a pre-existing psychiatric condition.
- Contre-indications
Do not use this product if you are taking, or have taken monoamine oxidase inhibitors in the past two weeks. Consult a health care practitioner / health care provider / health professional / doctor / physician before using if you are pregnant or breastfeeding.
- Effets indésirables connus
Stop use in case of restlessness, irritability, dizziness, tremor, severe headache, insomnia, loss of appetite, nausea, rapid heartbeat, shortness of breath and/or disturbance of urination.
Source
Official Health Canada record, licence 80096865
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed. Photograph the packaging